Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Resorption, Safety, and Efficacy of Absorbable Collagen Membrane in Preventing Significant Bone Loss Following GBR (Guided Bone Regeneration) Procedure.

NCT06570265 is registered in ClinicalTrials.gov with Hyundai Bioland Co., Ltd. as lead sponsor.

NCT NCT06570265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06570265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Resorption, Safety, and Efficacy of Absorbable Collagen Membrane in Preventing Significant Bone Loss Following GBR (Guided Bone Regeneration) Procedure.
Lead sponsor
Hyundai Bioland Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 16, 2024
Completion date
June 30, 2026
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

guided bone regeneration